Ausgabe 6/2010
Inhalt (21 Artikel)
Generic and therapeutic substitutions: are they always ethical in their own terms?
Mubarak AlAmeri, Miran Epstein, Atholl Johnston
Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism
Chaker Ben Salem, Lynda Ben Salah, Colandane Belajouza, Kamel Bouraoui
Severe akathisia as a side effect of metoclopramide
Arthur R. Van Gool, Jeanette K. Doorduijn, Caroline Seynaeve
Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in lebanon
Soumana C. Nasser, Jeanette G. Nassif, Fouad Mahfouz
Managing obesity in pharmacy: the Australian experience
Irene S. I. Um, Carol Armour, Ines Krass, Timothy Gill, Betty B. Chaar
Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients
Kwua-Yun Wang, Chih-Feng Chian, Hsiang-Ru Lai, Yen-Huei Tarn, Chin-Pyng Wu
The Pharmaceutical care of patients with type 2 diabetes mellitus
Anna Paula de Sá Borges, Camilo Molino Guidoni, Lígia Domingues Ferreira, Osvaldo de Freitas, Leonardo Régis Leira Pereira
Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients
Tomoya Sakurada, Shinya Takada, Hisae Eguchi, Keishiro Izumi, Nobunori Satoh, Shiro Ueda
Association between drug prescribing and quality of life in primary care
Samanta E. Fröhlich, Anamaria V. Zaccolo, Sabrina L. C. da Silva, Sotero S. Mengue
Cardiovascular co-medication among users of antiobesity drugs: a population-based study
Merethe Omdal Amundsen, Bo Engdahl, Christian Berg, Hedvig Nordeng
The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure
Rixt Nynke Eggink, Albert W. Lenderink, Jos W. M. G. Widdershoven, Patricia M. L. A. van den Bemt
Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals
Francesc Puigventós, Bernardo Santos-Ramos, Ana Ortega, Esther Durán-García
Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study
Isabelle Krummenacher, Matthias Cavassini, Olivier Bugnon, Rebecca Spirig, Marie P. Schneider
Opinion comparison concerning future information technology in Finnish community pharmacies
Anna Marietta Westerling, Jaana Tuulikki Hynninen, Veikko Ewald Haikala, Marja S. Airaksinen
“Patients don’t lie”; a view on adherence in asthma
Claus Møldrup, Jonathan Stein, Birthe Søndergaard
Which factors predict the time spent answering queries to a drug information centre?
Linda A. Reppe, Olav Spigset, Jan Schjøtt
Diagnosing infections: a qualitative view on prescription decisions in general practice over time
Ingunn Björnsdóttir, Karl G. Kristinsson, Ebba Holme Hansen
The incidence of potential drug–drug interactions in elderly patients with arterial hypertension
Vesna Bacic-Vrca, Srecko Marusic, Viktorija Erdeljic, Slaven Falamic, Nives Gojo-Tomic, Dario Rahelic
Evaluation of three brands of drug interaction software for use in intensive care units
Adriano Max Moreira Reis, Silvia Helena De Bortoli Cassiani
Introduction of pharmaceutical expertise in a palliative care team in Sweden
Barbro Norrström, Ing-Britt Cannerfelt, Helen Frid, Kim Roos, Helena Ramström